Citation Impact
Citing Papers
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Regulatory T Cells
2000 StandoutNobel
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
Five new human cancer‐germline genes identified among 12 genes expressed in spermatogonia
2003
Antibody therapy of cancer
2012 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Cancer/testis antigens, gametogenesis and cancer
2005 Standout
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
The roles of IFNγ in protection against tumor development and cancer immunoediting
2002
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Theta-Bearing and Complement-Receptor Lymphocytes Are Distinct Populations of Cells
1971 Science
Oxidative inactivation of leukotriene C 4 by stimulated human polymorphonuclear leukocytes
1982 StandoutNobel
Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space.
1969
Tumor Necrosis Factor (TNF)
1985 StandoutScience
Relation of GIX antigen of thymocytes to envelope glycoprotein of murine leukemia virus.
1975
Constitutive synthesis of tumor necrosis factor in the thymus.
1992 StandoutNobel
Thymus dependence of theta-bearing cells in the peripheral lymphoid tissues of mice.
1970
IMMUNOGLOBULIN AND OTHER SURFACE ANTIGENS OF CELLS OF THE IMMUNE SYSTEM
1971
Endotoxin-induced cytokine gene expression in vivo. I. Expression of tumor necrosis factor mRNA in visceral organs under physiologic conditions and during endotoxemia.
1989
Cachectin and tumour necrosis factor as two sides of the same biological coin
1986 StandoutNatureNobel
Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70
2000 StandoutNobel
Demonstration of two distinct components in the early antigen complex of epstein‐barr virus‐infected cells
1971
Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells
1980
Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells.
1975
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
1983 StandoutScienceNobel
Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells
1976 StandoutNatureNobel
The Steroid and Thyroid Hormone Receptor Superfamily
1988 StandoutScience
Shock and Tissue Injury Induced by Recombinant Human Cachectin
1986 StandoutScienceNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Further description of theLy-5 system
1979
Antigenic Changes in Lymph-Node Cells after Administration of Antiserum to Thymus Cells
1969 Science
Cloning of Human Mineralocorticoid Receptor Complementary DNA: Structural and Functional Kinship with the Glucocorticoid Receptor
1987 StandoutScience
Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice
1984
Epstein–Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements
1984 StandoutNatureNobel
The two different receptors for tumor necrosis factor mediate distinct cellular responses.
1991
Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties
1978
Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows
1976 StandoutScience
Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease.
1985 StandoutNobel
Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids.
1979 StandoutNobel
Ly-4 , A New Locus Determining a Lymphocyte Cell-Surface Alloantigen in Mice
1973 StandoutNobel
Lymphotoxin ? An immunologic hormone with anticarcinogenic and antitumor activity
1982
Tumor rejection antigens of chemically induced sarcomas of inbred mice.
1986
Arachidonic acid metabolism in polymorphonuclear leukocytes
1979 StandoutNobel
Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.
1981 StandoutNobel
Cachectin: More Than a Tumor Necrosis Factor
1987 StandoutNobel
Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.
1991
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens
1998
SEROLOGICALLY DEMONSTRABLE ALLOANTIGENS OF MOUSE EPIDERMAL CELLS
1972
STUDIES ON THE DIFFERENTIATION OF THYMUS-DERIVED LYMPHOCYTES
1970
Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
1979 StandoutNobel
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
1990 StandoutScience
The HLA-dependent expression of testis-organizing H-Y antigen by human male cells
1978 StandoutNobel
Ly antigens as markers for functionally distinct subpopulations of thymus-derived lymphocytes of the mouse
1975 Nature
Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis.
1982 StandoutNobel
Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.
1983
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
1996 StandoutScienceNobel
An endotoxin-induced serum factor that causes necrosis of tumors.
1975 Standout
Alloantigen-induced T-cell proliferation: Lyt phenotype of responding cells and blocking of proliferation by Lyt antisera
1980
Effects of immobilized immune complexes on Fc- and complement-receptor function in resident and thioglycollate-elicited mouse peritoneal macrophages.
1979
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro
1985 StandoutScience
Cell surface antigens of clonal teratocarcinoma cells at various stages of differentiation
1975 StandoutNobel
Identity of the soluble ebv‐associated antigens of human lymphoid cell lines
1972
Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes
1980 StandoutNature
Binding of Thymus- and Bone Marrow-Derived Lymphoid Cells to Antigen-Derivatized Fibers
1972 StandoutNobel
Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae.
1986
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial Cells
1973 Standout
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity
2008
Altered transcription of genes coding for class I histocompatibility antigens in murine tumor cells.
1983
Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes
1998
Direct Evidence for the Presence of Epstein-Barr Virus DNA and Nuclear Antigen in Malignant Epithelial Cells from Patients with Poorly Differentiated Carcinoma of the Nasopharynx
1974 StandoutNobel
Immunoglobulin Gene Rearrangement in Immature B Cells
1980 StandoutScienceNobel
Genomic sequencing.
1984 Standout
Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
1977 StandoutNobel
Identification of a unique tumor antigen as rejection antigen by molecular cloning and gene transfer.
1986
Purification and Characterization of Mouse Hematopoietic Stem Cells
1988 StandoutScience
Retinoic acid inhibition of Epstein-Barr virus induction
1979 StandoutNatureNobel
A POPULATION OF LYMPHOCYTES BEARING A MEMBRANE RECEPTOR FOR ANTIGEN-ANTIBODY-COMPLEMENT COMPLEXES
1970
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
1986 StandoutNature
Role of first stimulating agents in the production of tumor necrosis factor
1984
Immunoglobulin synthesis by lymphoid cells transformed in vitro by Abelson murine leukemia virus
1979 Nobel
Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx
1970 StandoutNatureNobel
Role of human chromosome 11 in determining surface antigenic phenotype of normal and malignant cells. Somatic cell genetic analysis of eight antigens, including putative human Thy-1.
1985
Works of Old Lj being referenced
Tumor necrosis factor.
1976
The immunogenetics of differentiation in the mouse.
1978
Induction and immunological properties of tumor necrosis factor.
1978
Tumor necrosis factor.
1987
Definition of an antigenic system associated with Burkitt's lymphoma.
1967
Cancer immunology: the search for specificity.
1982
Genes controlling gp25/30 cell-surface molecules map to chromosomes X and Y and escape X-inactivation.
1985
Current enigmas in cancer research.
1973
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity
1994
Inhibition of leukemias in man by L-asparaginase.
1967
Jungbluth AA, Chen Y‐T, Stockert E., Busam KJ, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old LJ. Immunohistochemical analysis of NY‐ESO‐1 antigen expression in normal and malignant human tissues. International Journal of Cancer 2001; 92(6) 856–860.
2001
CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY.
1964
The soluble antigens of BALB/c sarcoma Meth-A: a relationship between a serologically defined tumor-specific surface antigen (TSSA) and the tumor-associated transplantation antigen (TATA).
1981